Translational Session

Let Them Flow: Cell-Based Therapies in Kidney Transplantation

November 08, 2019 | 02:00 PM - 04:00 PM

Location: 151, Walter E. Washington Convention Center

Session Description

Cell-based therapies, including the use of donor-derived and "off-the-shelf" T cells, are an exciting new approach for inducing tolerance and treating rejection, viral infections, and cancer. This session reviews current applications in the clinical setting.

Learning Objective(s)

  • Describe the range of application of cell-based therapies in transplantation, including tolerance induction and treatment of rejection, cancer, and viral infections
  • Discuss the different approaches to using T regulatory cells in tolerance induction
  • Explain how T cells can be modified to target specific antigens
  • Describe the difference between donor-derived and off-the-shelf T-cell therapies
  • Understand the rationale for use of T regulatory cells to treat sub-clinical rejection

Learning Pathway(s)

  • Transplantation/Immunology


  • Vineeta Kumar, MD
  • Jonathan S. Maltzman, MD, PhD